Description
CUSTOM DOSED CHEMOTHERAPY IV MEDICATIONS FOR THE VA BALTIMORE MEDICAL CENTER.
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2024-06-27+$500,000= $500,000
- Mod P000012025-08-19-$444,794= $55,206
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2024-06-27 | +$500,000 | $500,000 | CUSTOM DOSED CHEMOTHERAPY IV MEDICATIONS FOR THE VA BALTIMORE MEDICAL CENTER. |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2025-08-19 | −$444,794 | $55,206 | CUSTOM DOSED CHEMOTHERAPY IV MEDICATIONS FOR THE VA BALTIMORE MEDICAL CENTER. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI K5MHR9JB9ND5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25526N0168 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · Q517 · PHARMACY SERVICES | $0 | FY2026 |
| 36C26126P0374 | 261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS | $156,000 | FY2026 |
| 36C24226N0311 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $200,000 | FY2026 |
| 36C24226N0309 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $269,557 | FY2026 |
| 36C26026N0063 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q517 · PHARMACY SERVICES | $557 | FY2026 |
| 36C24226N0127 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $20,584 | FY2026 |
Other recipients under 6505 from 245-NETWORK CONTRACT OFFICE 5 (36C245) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24526N0840 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $19,139 | FY2026 |
| 36C24526N0839 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $38,360 | FY2026 |
| 36C24526N0837 | QOL MEDICAL LLC | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,945 | FY2026 |
| 36C24526N0835 | TAKEDA PHARMACEUTICALS AMERICA, INC. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $34,605 | FY2026 |
| 36C24526N0834 | GALDERMA LABORATORIES, L.P. | 245-NETWORK CONTRACT OFFICE 5 (36C245) | $16,960 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24524P0649_3600_-NONE-_-NONE- · retrieved 2026-09-26.